Yasuhisa Fujii

机构：Institute of Science Tokyo · ORCID：0000-0002-6761-3229

发表论文 992 篇 · 总被引 11424 次 · h-index 51

代表论文

Re-evaluating Treatments for Advanced Urothelial Carcinoma Using Restricted Mean Survival Time: A Systematic Review and Network Meta-analysis (2026 · European Urology Open Science · 被引 4)
Clinical Features and Risk Factors of Enfortumab Vedotin–Induced Peripheral Neuropathy in Patients With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study ( YUSHIMA Study) (2025 · International Journal of Urology · 被引 4)
Bayesian Reanalysis of Enzalutamide Plus Androgen Deprivation Therapy in Japanese Patients With Metastatic Hormone‐Sensitive Prostate Cancer: A Methodological Complement to Frequentist Analysis From the ARCHES Trial (2025 · International Journal of Urology · 被引 4)
Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial (2026 · The Lancet · 被引 3)
Delayed Survival Benefit of Enzalutamide Plus Radium‐223 in Metastatic Castration‐Resistant Prostate Cancer: A Time‐Dependent Analysis of Reconstructed Individual Patient Data From the PEACE ‐3 Trial (2026 · International Journal of Urology · 被引 3)
Comparative prognostic performance of KEYNOTE-564 and AUA risk stratification in nonmetastatic clear cell renal cell carcinoma (2025 · Urologic Oncology Seminars and Original Investigations · 被引 3)